CymaBay Therapeutics Inc.
News
CymaBay Therapeutics (NASDAQ:CBAY) Coverage Initiated at StockNews.com
Ticker Report Investment analysts at StockNews.com began coverage on shares of CymaBay Therapeutics (NASDAQ:CBAY Get Free Report) in a research report issued on Monday. The firm set a sell”...\n more…
Gilead Sciences Bolsters Portfolio with CymaBay Acquisition
TipRanks Financial Blog Gilead Sciences (GILD) has shared an update. Gilead Sciences, Inc. successfully completed its acquisition of CymaBay Therapeutics, Inc., marking a significant move ...\n more…
CymaBay Therapeutics: Major Acquisition and Leadership Overhaul
TipRanks Financial Blog The latest announcement is out from CymaBay Therapeutics (CBAY). In a significant move for investors, a tender offer for all outstanding shares of a company commenc...\n more…
Gilead Sciences Announces Completion of Acquisition of CymaBay
Business Wire Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in...\n more…
CymaBay Therapeutics (NASDAQ:CBAY) Now Covered by Analysts at StockNews.com
Ticker Report Investment analysts at StockNews.com assumed coverage on shares of CymaBay Therapeutics (NASDAQ:CBAY Get Free Report) in a note issued to investors on Sunday. The brokerage set a...\n more…